| Literature DB >> 20207138 |
Paul J Coleman1, John D Schreier, Georgia B McGaughey, Michael J Bogusky, Christopher D Cox, George D Hartman, Richard G Ball, C Meacham Harrell, Duane R Reiss, Thomayant Prueksaritanont, Christopher J Winrow, John J Renger.
Abstract
Orexins are neuropeptides that regulate wakefulness and arousal. Small molecule antagonists of orexin receptors may provide a novel therapy for the treatment of insomnia and other sleep disorders. In this Letter we describe the design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as orexin receptor antagonists. The design of these constrained analogs was guided by an understanding of the preferred solution and solid state conformation of the diazepane central ring. 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20207138 DOI: 10.1016/j.bmcl.2010.01.138
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823